Quantcast

Latest Quintiles Stories

2014-09-09 08:31:23

MALVERN, Pa., Sept. 9, 2014 /PRNewswire/ -- Y-Prime, Inc., a premier eClinical products and consulting company, today announced the appointment of Richard Gastineau as Chief Operating Officer and General Counsel. Gastineau will lead many of the company's key business operations, including finance, revenue reporting, sales, legal affairs and human resources. Gastineau is an attorney and accomplished entrepreneur who brings to Y-Prime more than 20 years of progressive success in...

2014-08-28 23:07:25

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Kristen DeVito, Global Director Clinical Supply Services, and Chris Greco, Manager, Comparator and Ancillary Supplies, will present “Critical Path Sourcing Strategies for Active Control Clinical Trials” at the forthcoming US Clinical Trials Supply Conference, which takes place on the 9th – 10th...

2014-08-11 12:27:45

AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer, Sanofi, Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc. ELLICOTT CITY, Md., Aug. 11, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing...

2014-08-06 12:29:33

SARASOTA, Fla., Aug. 6, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has made two key independent appointments to the Company's Board of Directors with the recent election of Ms. Lee M. Canaan, CFA and Mr. Edward J. McDonnell, MPH. as new directors. http://photos.prnewswire.com/prnvar/20140806/134113 Both Ms. Canaan and Mr. McDonnell have substantial expertise, experience and knowledge relevant to the Company's mission and...

2014-08-05 12:31:12

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China,...

2014-08-04 08:29:13

FRAMINGHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., as Chief Medical Officer of HeartWare, effective September 1, 2014. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience...

2014-07-24 23:08:33

This webinar will provide best practice insights into dose selection for First in Human (FIH) dose escalation studies to mitigate risk and optimize the value of your early clinical data. The live broadcast will be taking place on Wednesday, August 6, 2014 @ 10am EDT / 3pm BST (UK GMT +1). Toronto, Canada (PRWEB) July 24, 2014 The first part of the session on “Best Practices for Optimizing Dose Escalation in First in Human Studies” will cover comprehensive clinical support in early...

2014-07-17 23:07:23

In this webinar, the presenters will share examples of delivering effective programs that achieved greater resource efficiencies and improved data quality nearly twofold better than industry benchmarks. The live broadcast will be taking place on Thursday, July 31, 2014 @ 11am EDT / 4pm BST (UK GMT +1). Toronto, Canada (PRWEB) July 17, 2014 Risk-based Monitoring (RBM) is a new way to facilitate more efficient trial delivery. The Food and Drug Administration (FDA) and European Medicines...

2014-07-01 08:30:55

DUBLIN, July 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7xtphb/pharmacovigilance) has announced the addition of the "Global Pharmacovigilance (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has...

2014-06-19 23:11:43

In this webinar, speakers Wendy Stewart, VP and Integrated Site Start up at Quintiles along with Sam Searcy, Associate Contracts Services Director and Global Regulatory Start Up at Quintiles, will demonstrate how some strategies, processes, and technology help maximize productivity and reduce cycle times. The live broadcast will be taking place on Thursday, July 10, 2014 at 11 a.m. EDT / 4p.m. BST (UK GMT +1). Toronto, Canada (PRWEB) June 19, 2014 In the early stages of a clinical study,...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.